Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Privigen Market Expansion From $ Billion In 2026 To $ Billion In 2030
The historical growth was driven by the expansion of plasma donation networks, an increasing number of diagnoses for primary immunodeficiency disorders, greater access to plasma-derived treatments, enhanced clinical standards for intravenous immunoglobulin (IVIG) usage, and the development of infusion services within hospitals.
The expansion during the forecast period is driven by a growing need for extended immunotherapy regimens, the broadening of homecare infusion options, increased funding for plasma supply reliability, a higher incidence of autoimmune diseases, and enhanced production effectiveness for intravenous immunoglobulin (IVIG) products. Key trends shaping this period encompass a rising preference for immunoglobulin-based treatments, the development of plasma collection facilities, greater adoption of at-home IVIG delivery, advancements in plasma fractionation methods, and an intensified emphasis on managing chronic immune conditions.
Download A Free Sample Report For Comprehensive Market Insights:
Privigen Market Development Factors: Which Trends Are Supporting Demand?
The growing frequency of immunodeficiency disorders is anticipated to boost the privigen market in the coming years. Immunodeficiency disorders are characterized by a weakened immune system that struggles to protect the body from infections and diseases. Their prevalence is on the rise due to heightened awareness, improved diagnostic methods, extended survival rates among those with primary immunodeficiencies, increased application of immunosuppressive therapies, and a greater incidence of chronic illnesses. Privigen, a type of intravenous immunoglobulin (IVIG), is employed in managing immunodeficiency disorders by elevating antibody levels, enabling patients to effectively combat infections and sustain immune function. For example, in May 2023, the University of Oxford reported that the 19 most common autoimmune diseases impacted 3–9% of the United Kingdom’s population in 2022, a figure that climbed to 10% in 2023. Consequently, the escalating prevalence of immunodeficiency disorders is propelling the privigen market.
Supportive government initiatives are expected to drive the privigen market forward. These initiatives encompass healthcare programs, policies, or actions implemented by authorities to enhance public health, expand medical service access, and foster population well-being. Their rise is fueled by factors like a growing need for affordable and reachable medical services, efforts to address aging populations and chronic diseases, and progress in medical technology. Government initiatives that back immunodeficiency treatments improve accessibility to therapies such as privigen, guaranteeing patients receive timely and cost-effective care through funding and healthcare schemes. As an illustration, in February 2023, the National Institute for Health and Care Research, a UK funding body, disclosed that funding for the NIHR BioResource—which uses genetic information to develop new tests and treatments for rare diseases like immunodeficiencies and hemophilia—was $50.89 million in 2022, escalating to $1005.17 million in 2023. Thus, the uptick in favorable government initiatives is advancing the privigen market.
Increasing healthcare expenditure is projected to fuel the privigen market moving ahead. Healthcare expenditure refers to the total financial resources allocated to medical services, healthcare infrastructure, pharmaceuticals, and related activities. This spending is rising due to elevated operational costs in healthcare facilities, a higher prevalence of chronic and lifestyle-linked diseases, growing occurrences of genetic disorders, technological advancements in medicine, and expanded healthcare access. Greater healthcare expenditure enhances availability of treatments like privigen for immunodeficiency disorders, boosting treatment access, patient outcomes, and overall healthcare systems. For instance, in May 2024, a report from the Office for National Statistics, a UK government agency, indicated that total healthcare expenditure grew by 5.6% in nominal terms from 2022 to 2023, compared to a 0.9% increase in 2022. Moreover, total long-term health and social care spending rose by 2.8% in real terms in 2022. Therefore, the rise in healthcare expenditure is driving the privigen market.
Privigen Market Segmentation: How Is The Market Structured Across Key Categories?
The privigen market covered in this report is segmented –
1) By Formulation: Liquid (10% solution), Lyophilized
2) By Indication: Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome, Other Autoimmune Disorders
3) By End Users: Hospitals, Clinics, Homecare settings
Privigen Market Competitive Landscape And Leading Companies
Major companies operating in the privigen market are CSL Behring AG
Access The Complete Privigen Market Report:
Privigen Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the privigen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the privigen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model